Karsten Mueller1, Robert Jech2,3, Cecilia Bonnet2,3, Jaroslav Tintěra4, Harald E Möller1, Klaus Fassbender5, Jan Kassubek6, Markus Otto6, Evžen Růžička2,3, and Matthias L Schroeter1,7
1Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany, 2Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, Prague, Czech Republic, 31st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic, 4Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 5Clinic and Polyclinic for Neurology, Saarland University Homburg, Homburg, Germany, 6Clinic and Polyclinic for Neurology, University of Ulm, Ulm, Germany, 7Clinic for Cognitive Neurology, University Hospital Leipzig, Leipzig, Germany
Synopsis
Structural
brain differences were investigated between patients with progressive
supranuclear palsy (PSP) and healthy controls with T1-weighted
images (MP-RAGE) acquired at four centers with different 3T scanners
(Siemens). Using voxel-based morphometry, we found a major decline in
gray matter density in brainstem, insula, striatum, and frontomedian
regions that is in line with the current literature.
Support-vector-machine classification provided a high sensitivity of
disease detection when using relevant brain regions in feature
selection.Purpose
Progressive
supranuclear palsy (PSP) is a neurodegenerative disease that is characterized clinically by atypical parkinsonism, supranuclear
palsy, postural instability, mild dementia, and
neuropathologically by the accumulation of tau protein resulting in
neurofibrillary tangles.
1
It is associated with structural changes in the midbrain
(“hummingbird” or “penguin sign”), but recent meta-analyses
show that other brain regions, predominantly in striatum and insula,
are also affected.
2
To
further investigate PSP and structural brain changes caused by this
rare disease, a set of patients was investigated using a
multi-centric approach.
Methods
20
PSP patients (7 female, 67.3±7.8 years) were compared to 20 matched
healthy controls (8 female, 66.3±7.8 years). T1-weighted images
(MP-RAGE) were acquired at four different centers employing Siemens
3T scanners (Trio, Allegra, Skyra, Verio).
Voxel-based
morphometry3
was performed with SPM and the VBM8 toolbox. Gray-matter-density
(GMD) images4
were generated using the unified segmentation approach and smoothed
with an 8mm Gaussian kernel. Voxel-wise statistical analysis
(two-sample t-test
PSP patients vs. controls) was computed controlling for age, sex, and
total intracranial volume. The significance level was set at p<0.05,
family-wise error (FWE) corrected threshold on the cluster level.5
To
study effects induced by a single center, and to assess
between-center variability, statistical analyses were performed
separately for Prague, Czech Republic (uni-center approach), and for
three German centers (Ulm, Homburg, Leipzig; multi-center approach).
A conjunction analysis was performed between the Prague and the
German cohorts to investigate the overlap of the results. A further
test of between-center variability was performed by merging the
participants from Prague and from one of the three German centers to
generate three cohorts for another conjunction analysis of the maximum
overlap.
Support-vector-machine
(SVM) classification (patients vs. controls) was performed with GMD
images using the libSVM software package.6
Classification accuracy was assessed by generating a set of 400
models with leaving a patient and a control subject out when building
the classifier. Thereafter, it was checked if both remaining data
sets were classified correctly. To assess the stability of
classification results, two different kernels (linear, polynomial) and
two different approaches of feature selection were compared. First,
voxels were used with SPM's GM tissue probability map with a minimum GM
probabilitiy using various thresholds between 0 and 80%. Second, ROIs were defined with the
WFU-Pickatlas selecting striatum, thalamus, caudate, and midbrain, as
suggested as PSP’s core network.1,2
Finally, a model was generated from all subjects, and relevant voxels
for classification were detected.
Results
Comparing
patients and controls, a diminished GMD was observed in brainstem,
thalamus, left and right anterior insulae, and in the vicinity of
putamen (Fig. 1). Less prominent differences were detected in lateral
orbitofrontal regions. Consistent results were obtained when
investigating GMD differences in the multi-centric German cohort
(Fig. 2). The conjunction analysis comparing the Prague and the
German cohort is shown in Fig. 3 with an overlap of reduced GMD in
the striatum and insular cortex (yellow). The German cohort showed
prominent GMD reductions in brainstem (red) while the Prague cohort
also showed diminished GMD in frontomedian regions (blue). Fig. 4
shows the conjunction between three cohorts obtained by merging
participants from Prague and one German center with an overlap in
striatum, insula, caudate, and frontomedian regions (yellow).
Using
SVM with a polynomial kernel and feature selection of voxels with GM
tissue probability >0.4, patients and controls were detected with
a classification accuracy of 79 and 84%, respectively (sensitivity
0.83; specificity 0.80). Other masks yielded similar accuracies. With
a linear kernel, accuracies to classify patients were lower (≈70%).
The ROI-based approach focusing on striatum and midbrain outperformed
the inclusion of all GM voxels (Fig. 5; accuracies of 84 and 86% for
patients and controls, respectively; sensitivity 0.86, specificity
0.85). Both approaches yielded higher sensitivity of disease
detection than specificity of correctly classified controls. Relevant
voxels for classification were located in brain stem, striatum, and
caudate, but also in cerebellar regions (Fig. 5).
Conclusion
In
line with previous work,
7-9
we found disease-related GMD decrease using a multi-centric approach. The specific pattern of brain atrophy is essential for understanding
neuropathological mechanisms in PSP. Brain regions affected by PSP
showed a high relevance for correct classification from controls as a
precondition for future therapy.
Further
development of SVM-based classification might complement the
radiologist’s MRI-based diagnostics for PSP disease detection and
characterization.
Acknowledgements
Supported
by IGA
MZ CR NT12282-5/2011 and NT/12288-5/2011, PRVOUK P26/LF1/4;
PDF-IRG-1307, BMBF Kompentenznetze Neurodegenerative Demenzen,
Michael
J Fox Foundation.References
1. Williams DR, Lees AJ. Progressive supranucler palsy:
Clinicopathological concepts and diagnostic challenges. Lancet
Neurol. 2009;8(3):270-279
2. Shi HC, Zhong JG, Pan PL, et al. Gray matter atrophy in progressive
supranuclear palsy: meta-analysis of voxel-based morphometry studies.
Neurol Sci. 2013;34(7):1049-1055.
3. Ashburner J, Friston KJ. Voxel-based morphometry—the
methods. NeuroImage 2000;11(6):805-821.
4. Ashburner J, Friston KJ. Unified segmentation. NeuroImage
2005;26(3):839-851.
Unified
segmentation.
5. Nichols T. Controlling the familywise error rate in functional
neuroimaging: A comparative review. Stat Methods Med Res.
2003;12:419-446.
6. Chang CC, Lin CJ. LIBSVM: A library for support vector machines. ACM
TIST. 2011;2(3):e27.
7. Price S, Paviour D, Scahill R, et al. Voxel-based morphometry detects
patterns of atrophy that help differentiate progressive supranuclear
palsy and Parkinson's disease. NeuroImage 2004;23(2):663-669.
8. Cordato NJ, Duggins AJ, Halliday GM, et al. Clinical deficits
correlate with regional cerebral atrophy in progressive supranuclear
palsy. Brain 2005;128(6):1259-1266.
9. Ghosh BCP, Calder AJ, Peers PV, et al. Social cognitive deficits and
their neural correlates in progressive supranuclear palsy. Brain
2012;135(7):2089-2102.